Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists
作者:Shilan Liu、Yinhui Liu、Hongmei Wang、YiLi Ding、Hao Wu、Jingchao Dong、Angela Wong、Shu-Hui Chen、Ge Li、Manuel Chan、Nicole Sawyer、Francois G. Gervais、Martin Henault、Stacia Kargman、Leanne L. Bedard、Yongxin Han、Rick Friesen、Robert B. Lobell、David M. Stout
DOI:10.1016/j.bmcl.2009.08.014
日期:2009.10
We describe herein a novel series of 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective inhibitors against the CXCR2 chemokine receptor and IL-8-mediated chemotaxis of a CXCR2-expressing cell line. Furthermore, these alkyl-hydrazine series inhibitors such as 5b demonstrated acceptable metabolic stability when incubated in human and rat microsomes. (C) 2009 Published by Elsevier Ltd.
US4675445A
申请人:——
公开号:US4675445A
公开(公告)日:1987-06-23
[EN] NOVEL HYDRAZINO-CYCLOBUT-3-ENE-1, 2-DIONE DERIVATIVES AS CXCR2 ANTAGONISTS<br/>[FR] NOUVEAUX DÉRIVÉS D'HYDRAZINOCYCLOBUT-3-ÈNE-1,2-DIONE COMME ANTAGONISTES DE CXCR2
申请人:MERCK SHARP & DOHME
公开号:WO2010091543A1
公开(公告)日:2010-08-19
The present invention relates to novel hydrazino-cyclobut-3-ene-1,2-dione compounds of Formula (I) as selective CXCR2 antagonists, pharmaceutical compositions containing the novel compounds, as well as methods for treating or preventing chemokine mediated diseases or conditions in human and non-human animals using the novel compounds (I).